Syngenta's sales fell 10% to $5.2bn in the third quarter of 2026, from $5.7bn a year earlier, and EBITDA slipped 2% to $800m, or 4% at constant exchange rates, the company reported.
It said persistent drought and unusually hot weather across Europe reduced demand for crop protection by holding back crop development and the chances to spray. Pressure on farm incomes made growers more cautious about buying seed and crop protection, purchases were delayed in several markets, and the company is deliberately shrinking some lower-margin businesses.
Over the first nine months, sales were $17.3bn, down 5% from $18.2bn, but EBITDA rose 1% to $3.2bn and the EBITDA margin improved by 100 basis points to 18.4%. Leaving out the planned cut in grain trading and other low-margin activities, underlying sales grew 1%.
Sales of newly launched technologies kept growing and helped offset pricing pressure on off-patent crop protection products, particularly in Brazil and the rest of Latin America. Biologicals grew by double digits in the third quarter, and the newer products TYMIRIUM and PLINAZOLIN continued to expand.
Syngenta also changed its management: Gaël Hili, president and chief executive of ADAMA, becomes president of Syngenta Seeds on 1 November, and Dr Zhigang Hao, chief executive of the animal nutrition company Adisseo, takes over at ADAMA.
AgNavigator, which reported the results, noted that the company is targeting a Hong Kong stock market listing in 2027, after pushing back an earlier goal of 2026.
Photo: Latschari / Wikimedia Commons (CC BY-SA 3.0)
Source: AgNavigator
Comments
(0)